Marc Bracke
Overview
Explore the profile of Marc Bracke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
4267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
De Clercq K, Schelfhout C, Bracke M, de Wever O, Van Bockstal M, Ceelen W, et al.
Biomaterials
. 2016 May;
96:33-46.
PMID: 27135715
Background: Peritoneal adhesions are a common complication after abdominal surgery. They cause small bowel obstruction, female infertility and chronic abdominal pain. Peritoneal adhesions also hamper uniform drug distribution in the...
12.
De Vlieghere E, Carlier C, Ceelen W, Bracke M, de Wever O
Data Brief
. 2016 Feb;
6:542-9.
PMID: 26904717
This data paper contains information about the in vivo model for peritoneal implants used in the paper "Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells"...
13.
Feys L, Descamps B, Vanhove C, Vermeulen S, Vandesompele J, Vanderheyden K, et al.
In Vivo
. 2015 Dec;
30(1):1-11.
PMID: 26709122
Background: Bioluminescent cancer models are widely used but detailed quantification of the luciferase signal and functional comparison with a non-transfected control cell line are generally lacking. In the present study,...
14.
Feys L, Descamps B, Vanhove C, Vral A, Veldeman L, Vermeulen S, et al.
Oncotarget
. 2015 Sep;
6(29):26615-32.
PMID: 26396176
Radiotherapy is a mainstay in the postoperative treatment of breast cancer as it reduces the risks of local recurrence and mortality after both conservative surgery and mastectomy. Despite recent efforts...
15.
Umelo I, de Wever O, Kronenberger P, Noor A, Teugels E, Chen G, et al.
Lung Cancer
. 2015 Sep;
90(2):167-74.
PMID: 26342549
Introduction: Lung cancer remains the leading cause of cancer-related mortality worldwide, with metastatic disease frequently a prominent feature at the time of diagnosis. The role of NSCLC-derived EGFR mutations in...
16.
De Vlieghere E, Verset L, Demetter P, Bracke M, de Wever O
Virchows Arch
. 2015 Aug;
467(4):367-82.
PMID: 26259962
Cancer-associated fibroblasts (CAFs) are drivers of tumour progression and are considered as a target and a tool in cancer diagnostic and therapeutic applications. An increased abundance of CAFs or CAF...
17.
Verset L, Tommelein J, Moles Lopez X, Decaestecker C, Boterberg T, De Vlieghere E, et al.
Radiother Oncol
. 2015 May;
116(3):449-54.
PMID: 26021554
Background And Purpose: Cancer-associated fibroblasts (CAFs) are increasingly recognised as promoters of tumour progression. It is poorly investigated whether cancer management protocols, such as neoadjuvant radio(chemo)therapy, have an impact on...
18.
Lambooij B, Bracke M, Reimert H, Foss A, Imsland A, van de Vis H
Physiol Behav
. 2015 May;
149:23-8.
PMID: 26003496
Behavioural, neural and physiological aspects related to pre-slaughter cooling of turbot habituated to two environmental temperatures (18.7 and 12.0°C) were investigated. Six fish in both treatments were immersed in ice...
19.
Microbial inhibition of oral epithelial wound recovery: potential role for quorum sensing molecules?
De Ryck T, Vanlancker E, Grootaert C, Roman B, De Coen L, Vandenberghe I, et al.
AMB Express
. 2015 May;
5:27.
PMID: 25995981
Awareness of the impact of microbiota in both health and disease is growing. Using a new in vitro oral mucosa co-culture model, we recently showed a clear inhibition of epithelial...
20.
Umelo I, de Wever O, Kronenberger P, Van Deun J, Noor A, Singh K, et al.
Oncotarget
. 2015 May;
6(24):20132-44.
PMID: 25992771
KRAS is a frequently mutated oncogene in lung cancer and among the most refractory to EGFR targeted therapy. Recently, preclinical evidence in pancreatic cancer has demonstrated that mutant KRAS can...